Kyverna Therapeutics

HQ
Emeryville
55 Total Employees
Year Founded: 2018

Kyverna Therapeutics Benefits Overview

Compensation + Benefits

Offers 401(K)

Offers life insurance

Offers accidental death & dismemberment insurance

Offers disability insurance

Offers supplemental life insurance

Offers company equity

Offers performance bonuses

Offers dental insurance

Offers health insurance

Offers mental health benefits

Offers dependent care

Offers Flexible Spending Account (FSA)

Offers vision insurance

Offers Health Savings Account (HSA)

Provides family medical leave

Offers generous parental leave

Company Culture

Provides commuter benefits

Offers legal assistance

Provides free snacks and drinks

Offers a remote work program

Career Growth + Development

Provides customized development tracks

Work-Life Balance + Wellbeing

Offers generous PTO

Provides paid sick days

Provides military leave

Provides paid holidays

Provides bereavement leave

Offers an Employee Assistance Program (EAP)

Biotech
Manage end-to-end accounts payable via the Coupa P2P platform: vendor onboarding and maintenance, invoice processing and matching, payment batching, reconciliations, vendor inquiries/escalations, 1099/ W-9/W-8 compliance, expense and corporate card support, and month-end close activities.
Biotech
Lead cross-functional asset strategy across the full product lifecycle for cell therapy programs, overseeing development, process validation, manufacturing readiness, regulatory filings, launch planning, and lifecycle expansion while aligning portfolio, commercial, and technical teams and managing partnerships, timelines, risks, and budgets.
Biotech
Lead global regulatory strategy for Kyverna's cell therapy portfolio across development, approval, and commercialization. Drive labeling strategy, health authority engagements (FDA, EMA), regulatory submissions (INDs, BLAs/MAAs), and cross-functional alignment with Clinical, CMC, Commercial, Market Access, and Legal. Mentor and scale the regulatory team, manage external partners, and provide regulatory input for business development and portfolio decisions to enable launch readiness and lifecycle management.